Amphastar Pharmaceuticals, Inc. (AMPH) vs Avalyn Pharma Inc. Common Stock (AVLN)

A side-by-side comparison of Amphastar Pharmaceuticals, Inc. and Avalyn Pharma Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AMPH vs AVLN

growth of $100 · dividends reinvested · last 1y
AMPH +17.2% (+17.2%/yr)AVLN -8.3% (-8.3%/yr)AMPH compounded faster over this window
8090100110120130Start $100$117$92
AMPH AVLN

AMPH vs AVLN: by the numbers

  • •AVLN is the larger company ($1.20B vs $1.12B market cap).
  • •AMPH is profitable (10.76% net margin) while AVLN runs a net loss (0.00%).

Metrics side by side

Valuation

MetricAMPHAVLN
P/E ratio15.01N/A
Forward P/E8.54N/A
PEG ratio0.11N/A
P/S ratio1.53N/A
P/B ratio1.463.01
EV / EBITDA8.82N/A
FCF yield13.67%N/A

Profitability

MetricAMPHAVLN
Gross margin47.68%0.00%
Operating margin15.66%0.00%
Net margin10.76%0.00%
ROE10.23%N/A
ROIC5.93%-67.73%

Growth (annualized)

MetricAMPHAVLN
Revenue CAGR (5Y)13.71%N/A
EPS CAGR (5Y)134.23%N/A
FCF CAGR (5Y)23.90%N/A
Total return CAGR (5Y)6.13%N/A

Frequently asked

Is AMPH or AVLN more profitable?
AMPH runs the higher net margin — AMPH at 10.76% versus AVLN at 0.00%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.